FLGT FY 2015 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$449M

FY 2015 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$10M+649.3% YoY

Gross Profit

$5M47.1% margin

Operating Income

-$5M-52.3% margin

Net Income

-$8M-86.8% margin

EPS (Diluted)

$-0.64

Cash Flow

Operating Cash Flow

-$969,000

Free Cash Flow

-$3M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$6M

Total Liabilities

$686,000

Stockholders' Equity

$5M

Cash & Equivalents

$489,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$1M	+649.3%
Gross Profit	$5M	$342,000	+1217.8%
Operating Income	-$5M	-$990,000	-406.3%
Net Income	-$8M	-$4M	-94.1%